Skip to main content

News

Keep up-to-date with the latest news from Sonic Healthcare USA

 

Media Inquiries:

Please contact press@sonichealthcareusa.com

Sonic Healthcare USA Donating $100K to Maui Relief

Monday, 30 October 2023

In the devastation that followed the tragic wildfires this past August, burning through hundreds of acres on the island of Maui, two of our Clinical Laboratories of Hawaii (CLH) locations in the Lahaina area suffered overwhelming loss...

Proteomics International and Sonic Healthcare USA sign exclusive license agreement to take PromarkerD to the US market

Wednesday, 10 May 2023

Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ) is pleased to announce it has signed an exclusive license agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd (OTCMKTS: SKHHY) for the use and commercialization of the Company's PromarkerD test for diabetic kidney disease in the United States. Proteomics International Laboratories Ltd (Proteomics International; the Company; ASX: PIQ) is pleased to announce it has signed an exclusive license agreement with Sonic Healthcare USA, a Division of Sonic Healthcare Ltd (OTCMKTS: SKHHY) for the use and commercialization of the Company's PromarkerD test for diabetic kidney disease in the United States. Under the agreement, Sonic Healthcare USA will be offering PromarkerD to physicians and healthcare systems through its client engagement teams across the US...

Sonic Healthcare USA Announces Testing Availability for Monkeypox

Monday, 18 July 2022

This week, Sonic Healthcare USA (Sonic) began testing for Monkeypox (MPXV), using the Centers for Disease Control and Prevention (CDC) Non-variola Orthopoxvirus, high complexity NAAT (RT-PCR) molecular assay...

Sonic Healthcare USA authorized by HHS to perform testing for the Monkeypox Virus

Tuesday, 05 July 2022

Sonic Healthcare USA (Sonic) was selected as one of five commercial laboratories authorized by the US Department of Health and Human Services (HHS)...

SARS-CoV-2 Omicron Variant of Concern

Sonic Healthcare USA

Wednesday, 22 December 2021

SARS-CoV-2 Omicron Variant of Concern

Sonic Healthcare USA to Offer Assay to Aid in the Selection of JEMPERLI (dostarlimab-gxly) Therapy in Endometrial Cancer

Austin, TX

Friday, 02 July 2021

LMC Pathology Services (LMC), a Sonic Healthcare USA Anatomic Pathology Practice, is the first reference laboratory in the United States to offer the VENTANA MMR RxDx...

Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program

Sonic Healthcare USA

Monday, 19 April 2021

Sonic Healthcare USA is announced as a Laboratory Testing Partner for National K-12 School Testing Program

Sonic Healthcare USA Enhances Test Offerings with the Launch of Multiplex Assay for COVID-19 and Flu

Wednesday, 07 October 2020

Sonic Healthcare USA has launched a multiplex RT-PCR assay that combines testing for SARS-CoV-2 (COVID-19) and Influenza A/B with a single specimen collection.

Sonic Healthcare USA to Expand COVID-19 Testing Capacity in the United States in Collaboration with the NIH RADx Initiative

Wednesday, 02 September 2020

Today, Sonic Healthcare USA (Sonic) was awarded a contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Advanced Technology Platforms (RADx-ATP) initiative.